Celcuity Form 144: Planned sale of 9,325 insider shares disclosed
Rhea-AI Filing Summary
Celcuity Inc. (NASDAQ: CELC) filed a Form 144 indicating the intent to sell 9,325 common shares, valued at roughly $420,766 based on the market price when the form was prepared. The shares, which equal about 0.02 % of the 37.9 million shares outstanding, were acquired through two stock-grant awards on 05/14/2022 (7,843 sh) and 05/12/2021 (1,482 sh). No cash consideration was paid for the grants.
The proposed sale is expected on or after 07/28/2025 through broker RBC Capital Markets, with execution on the NASDAQ market. The filer reported no other sales during the past three months and affirmed they possess no undisclosed material adverse information about the company. Form 144 is a notice only; execution is not guaranteed and volume limits under Rule 144 apply.
Given the modest size relative to CELC’s float and the routine nature of insider liquidity events, the filing is unlikely to be material for investors unless accompanied by additional insider activity or negative corporate developments.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small Rule 144 sale (0.02 % float); neutral impact absent wider insider trend.
The notice covers 9,325 shares—roughly $421k—earmarked for sale by an insider who received the stock via grants. Form 144 filings are common practice to comply with Rule 144’s volume and holding-period requirements and do not obligate the seller to complete the trade. The stake is immaterial to liquidity or control, and no concurrent sales were disclosed. Unless this filing precedes a pattern of larger disposals or coincides with negative news, it should have minimal valuation impact. Investors may monitor subsequent Form 4s to confirm execution.